Advertisement

Traws Pharma, Inc. TRAW

Set alert

Price alert · TRAW

All alert types
0.30 USD -0.01 -1.66%

At close · Oct 30

0.30 0.00 +1.18%

After hours · Oct 30, 4:00 PM ET

Bid
0.30 × 1
Ask
0.30 × 1
0.2876 Day range 0.3098
0.296 52-week range 2.82
YTD
-73.81%
1 year
-88.79%
Open
0.3098
Prev close
0.301
Mkt cap
4.55M
Vol
199.52K
Avg vol
582.99K
EPS
-1.71
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2876
High
0.3098
Forward P/E
-0.47
Beta
1.41
Short ratio
0.62
Inst. own
21.40%
Dividend
0.00
Ex-div date
50-d avg
4.96
200-d avg
11.13
1y target
6.00

5D chart

Chart tools
Interval

Signals (140)
NameTimeAgo
SMA: BearishOct 29, 1:15 PM2 days ago
MACD: Sell SignalOct 29, 1:15 PM2 days ago
SMA: BullishOct 29, 1:10 PM2 days ago
MACD: Buy SignalOct 29, 1:05 PM2 days ago
RSI: OversoldOct 29, 12:30 PM2 days ago
RSI: OversoldOct 29, 12:05 PM2 days ago
SMA: BearishOct 29, 12:00 PM2 days ago
SMA: BullishOct 29, 11:45 AM2 days ago
RSI: OversoldOct 29, 11:25 AM2 days ago
SMA: BearishOct 29, 11:00 AM2 days ago
MACD: Sell SignalOct 29, 11:00 AM2 days ago
SMA: BearishOct 29, 10:50 AM2 days ago
MACD: Buy SignalOct 29, 10:15 AM2 days ago
SMA: BullishOct 29, 10:10 AM2 days ago
MACD: Sell SignalOct 29, 10:00 AM2 days ago
SMA: BearishOct 29, 9:50 AM2 days ago
SMA: BullishOct 29, 9:30 AM2 days ago
SMA: BullishOct 29, 9:30 AM2 days ago
MACD: Buy SignalOct 29, 9:30 AM2 days ago
RSI: OverboughtOct 29, 9:30 AM2 days ago
MACD: Sell SignalOct 28, 3:40 PM3 days ago
SMA: BearishOct 28, 3:35 PM3 days ago
SMA: BearishOct 28, 3:35 PM3 days ago
MACD: Buy SignalOct 28, 2:35 PM3 days ago
SMA: BullishOct 28, 2:25 PM3 days ago
SMA: BullishOct 28, 2:25 PM3 days ago
SMA: BearishOct 28, 2:05 PM3 days ago
RSI: OversoldOct 28, 2:05 PM3 days ago
SMA: BullishOct 28, 1:30 PM3 days ago
MACD: Sell SignalOct 28, 1:25 PM3 days ago
SMA: BearishOct 28, 1:15 PM3 days ago
SMA: BearishOct 28, 1:15 PM3 days ago
MACD: Buy SignalOct 28, 12:40 PM3 days ago
SMA: BullishOct 28, 12:35 PM3 days ago
SMA: BullishOct 28, 12:35 PM3 days ago
SMA: BearishOct 28, 11:35 AM3 days ago
SMA: BearishOct 28, 10:55 AM3 days ago
SMA: BullishOct 28, 10:30 AM3 days ago
MACD: Sell SignalOct 28, 10:30 AM3 days ago
SMA: BearishOct 28, 10:20 AM3 days ago
SMA: BullishOct 28, 9:35 AM3 days ago
SMA: BullishOct 28, 9:35 AM3 days ago
MACD: Buy SignalOct 28, 9:35 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
MACD: Sell SignalOct 28, 9:30 AM3 days ago
RSI: OversoldOct 28, 9:30 AM3 days ago
MACD: Buy SignalOct 27, 3:20 PM4 days ago
RSI: OverboughtOct 27, 3:20 PM4 days ago
SMA: BullishOct 27, 3:15 PM4 days ago
MACD: Sell SignalOct 27, 3:00 PM4 days ago
SMA: BearishOct 27, 2:55 PM4 days ago
MACD: Buy SignalOct 27, 2:35 PM4 days ago
RSI: OverboughtOct 27, 2:35 PM4 days ago
SMA: BullishOct 27, 1:55 PM4 days ago
SMA: BullishOct 27, 1:55 PM4 days ago
SMA: BearishOct 27, 1:35 PM4 days ago
SMA: BearishOct 27, 1:10 PM4 days ago
MACD: Sell SignalOct 27, 1:00 PM4 days ago
SMA: BullishOct 27, 11:25 AM4 days ago
SMA: BullishOct 27, 11:25 AM4 days ago
MACD: Buy SignalOct 27, 11:15 AM4 days ago
SMA: BearishOct 27, 10:00 AM4 days ago
SMA: BearishOct 27, 10:00 AM4 days ago
MACD: Sell SignalOct 27, 10:00 AM4 days ago
RSI: OversoldOct 27, 10:00 AM4 days ago
SMA: BullishOct 27, 9:45 AM4 days ago
SMA: BullishOct 27, 9:45 AM4 days ago
MACD: Buy SignalOct 27, 9:45 AM4 days ago
MACD: Sell SignalOct 27, 9:35 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
SMA: BullishOct 26, 3:50 PM5 days ago
SMA: BullishOct 26, 3:50 PM5 days ago
MACD: Buy SignalOct 26, 3:50 PM5 days ago
MACD: Sell SignalOct 26, 3:30 PM5 days ago
SMA: BearishOct 26, 3:25 PM5 days ago
SMA: BearishOct 26, 3:25 PM5 days ago
SMA: BullishOct 26, 3:05 PM5 days ago
SMA: BullishOct 26, 3:05 PM5 days ago
MACD: Buy SignalOct 26, 3:05 PM5 days ago
MACD: Sell SignalOct 26, 2:50 PM5 days ago
SMA: BearishOct 26, 2:45 PM5 days ago
SMA: BearishOct 26, 2:45 PM5 days ago
SMA: BullishOct 26, 2:40 PM5 days ago
SMA: BullishOct 26, 2:40 PM5 days ago
MACD: Buy SignalOct 26, 2:40 PM5 days ago
SMA: BearishOct 26, 2:20 PM5 days ago
SMA: BearishOct 26, 2:20 PM5 days ago
MACD: Sell SignalOct 26, 2:20 PM5 days ago
SMA: BullishOct 26, 2:05 PM5 days ago
SMA: BearishOct 26, 2:00 PM5 days ago
SMA: BullishOct 26, 1:50 PM5 days ago
SMA: BullishOct 26, 1:50 PM5 days ago
MACD: Buy SignalOct 26, 1:50 PM5 days ago
MACD: Sell SignalOct 26, 1:45 PM5 days ago
SMA: BearishOct 26, 1:40 PM5 days ago
SMA: BearishOct 26, 1:40 PM5 days ago
SMA: BullishOct 26, 1:35 PM5 days ago
SMA: BullishOct 26, 1:35 PM5 days ago
SMA: BearishOct 26, 1:25 PM5 days ago
SMA: BearishOct 26, 1:25 PM5 days ago
SMA: BullishOct 26, 1:15 PM5 days ago
SMA: BullishOct 26, 1:15 PM5 days ago
MACD: Buy SignalOct 26, 1:15 PM5 days ago
MACD: Sell SignalOct 26, 1:10 PM5 days ago
SMA: BearishOct 26, 1:05 PM5 days ago
SMA: BullishOct 26, 12:50 PM5 days ago
SMA: BearishOct 26, 12:15 PM5 days ago
MACD: Buy SignalOct 26, 11:45 AM5 days ago
SMA: BullishOct 26, 11:30 AM5 days ago
SMA: BearishOct 26, 11:15 AM5 days ago
SMA: BullishOct 26, 11:10 AM5 days ago
SMA: BearishOct 26, 11:05 AM5 days ago
SMA: BullishOct 26, 10:55 AM5 days ago
SMA: BearishOct 26, 10:10 AM5 days ago
MACD: Sell SignalOct 26, 10:10 AM5 days ago
SMA: BearishOct 26, 9:55 AM5 days ago
RSI: OverboughtOct 26, 9:30 AM5 days ago
SMA: BullishOct 23, 3:40 PM1 week ago
SMA: BearishOct 23, 3:35 PM1 week ago
SMA: BullishOct 23, 3:30 PM1 week ago
SMA: BullishOct 23, 2:50 PM1 week ago
SMA: BearishOct 23, 2:40 PM1 week ago
SMA: BullishOct 23, 2:35 PM1 week ago
SMA: BearishOct 23, 2:25 PM1 week ago
SMA: BullishOct 23, 2:20 PM1 week ago
SMA: BearishOct 23, 2:15 PM1 week ago
MACD: Buy SignalOct 23, 2:05 PM1 week ago
SMA: BearishOct 23, 1:50 PM1 week ago
SMA: BullishOct 23, 1:45 PM1 week ago
RSI: OversoldOct 23, 1:20 PM1 week ago
MACD: Sell SignalOct 23, 1:15 PM1 week ago
SMA: BearishOct 23, 1:10 PM1 week ago
SMA: BearishOct 23, 1:05 PM1 week ago
MACD: Buy SignalOct 23, 12:40 PM1 week ago
SMA: BullishOct 23, 12:35 PM1 week ago
SMA: BullishOct 23, 12:35 PM1 week ago
SMA: BearishOct 23, 11:50 AM1 week ago
SMA: BullishOct 23, 11:00 AM1 week ago

Key statistics

Market cap
38.03M
Enterprise value
99.78M
Trailing P/E
0.00
Forward P/E
-0.47
PEG ratio
0.00
Price / sales
168.28
Price / book
0.99
EPS (TTM)
-135.78
Beta
1.41
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
226.00K
Revenue growth
0.00%
Free cash flow
-11.32M
Total cash
16.89M
Total debt
0
Return on equity
-1096.52%
Shares outstanding
3.03M
Short % of float
0.43%
50-day average
4.96
200-day average
11.13

Analyst view

Consensus: none

Price target (mean) 6.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
TRAW Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TRAW Net income — quarterly -2.61M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TRAW EPS — quarterly -0.16
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

TRAW recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 2024-6.25-8.81-2.56-40.96%
Aug 15, 2024Jun 1, 20240.00-121.75——
May 15, 2024Mar 1, 2024-6.00-6.000.000.00%

About Traws Pharma, Inc.

Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the recommended phase 2 dose for further development in endometrial cancer; and oral rigosertib, which is administered alone or in combination for investigation in various cancers. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on TRAW — it syncs with the Stock Master app.

Institution ownership

TRAW institution ownership
Holder% heldSharesValueReported
Orbimed Advisors LLC.20.01%605,5317.61MSep 29, 2024
Vanguard Group Inc0.88%26,722335.89KSep 29, 2024
Blackrock Inc.0.33%9,956125.15KSep 29, 2024
Bank of America Corporation0.07%2,13826.87KSep 29, 2024
Morgan Stanley0.02%7299.16KSep 29, 2024
UBS Group AG0.02%6307.92KSep 29, 2024

Fund ownership

TRAW fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.45%13,750172.84KSep 29, 2024
Vanguard Extended Market Index Fund0.43%12,879161.89KSep 29, 2024
Fidelity Extended Market Index Fund0.18%5,59770.35KOct 30, 2024
Fidelity Series Total Market Index Fund0.04%1,26715.93KOct 30, 2024
Fidelity Total Market Index Fund0.03%92611.64KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.02%5126.43KOct 30, 2024
Advertisement